Treatment Outcomes of Patients with G3 Neuroendocrine Neoplasms

#2769

Introduction: Extra-pulmonary neuroendocrine carcinomas (NEC) and neuroendocrine tumors (NET) G3 are aggressive neoplasia associated with a limited prognosis.

Aim(s): To characterize efficacy of different chemotherapies in NEN G3.

Materials and methods: 105 patients (♀=46;43.8% and ♂=59;56.2%) with NEC (n=83) or NET G3 (n=12) or MiNEN G3 (n=10) were analysed.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Jann H

Authors: Schenk J, Kayser A, Wiedenmann B, Tacke F, Roderburg C,

Keywords: NEN G3, Chemotherapy, Platinum, NEC G3, NET G3,

To read the full abstract, please log into your ENETS Member account.